< Home < Back

Sai Parenterals inks pact to acquire majority stake in Bion Therapeutics India

Date: 17-11-2026

Sai Parenterals, through its wholly owned subsidiary SP Analytics, has signed a definitive agreement to acquire a majority stake in Bion Therapeutics India (Bion), a Hyderabad-based branded formulations prescription business company. Bion will become a step-down subsidiary of Sai Parenterals on completion of the deal, which is expected before the end of this month. The transaction will be an all-cash deal.

Bion Therapeutics, founded in 2005, is a prescription based branded formulation company that builds products, manufactured with accredited contract manufacturing partners. Bion’s extensive infrastructure will provide Sai Parenterals with immediate access to a broader market, enhancing its competitive position in the domestic pharmaceutical landscape. With recent acquisition of Sai Prathyak Laboratories, in-house R&D centre with a portfolio of 174 molecules and 285 SKUs, Bion creates value addition and provides a commercial platform for Sai Parenterals with an established field team to take it to the prescription market. Bion’s existing management team will continue to spearhead the business following the completion of acquisition, retaining the doctor relationships and market knowledge on which the franchise rests.

Sai Parenterals, along with its subsidiaries, carries out contract research and manufacturing activities for customers engaged in pharmaceutical industries.